Portolan Capital Management, LLC Dyadic International Inc Transaction History

Portolan Capital Management, LLC

  • $1.26 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$3.36 - $5.34 $186,217 - $295,953
-55,422 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.3 - $6.49 $1.69 Million - $3.32 Million
-511,990 Reduced 90.23%
55,422 $308,000
Q2 2021

Aug 16, 2021
BUY
$3.35 - $5.67 $607,237 - $1.03 Million
181,265 Added 46.94%
567,412 $2.04 Million
Q1 2021

May 17, 2021
BUY
$4.75 - $6.87 $1.83 Million - $2.65 Million
386,147 New
386,147 $2.12 Million

Others Institutions Holding DYAI

# of Institutions
36
Shares Held
4.77M
Call Options Held
20.6K
Put Options Held
0
View Full List

About DYADIC INTERNATIONAL INC

DYAI Quotes by TradingView
  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $38.9M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email